Mozaffari Khadijeh, Willette Stephanie, Lucker Ben F, Kovar Sarah E, Holguin Francisco Omar, Guzman Ivette
Department of Plant and Environmental Sciences, New Mexico State University, Las Cruces, NM 88003, USA.
Trait Biosciences, Los Alamos, NM 87544, USA.
Molecules. 2021 Jun 11;26(12):3573. doi: 10.3390/molecules26123573.
Cannabidiol (CBD) is a hydrophobic non-psychoactive compound with therapeutic characteristics. Animal and human studies have shown its poor oral bioavailability in vivo, and the impact of consuming lipid-soluble CBD with and without food on gut bioaccessibility has not been explored. The purpose of this research was to study the bioaccessibility of CBD after a three-phase upper digestion experiment with and without food, and to test lipase activity with different substrate concentrations. Our results showed that lipase enzyme activity and fatty acid absorption increased in the presence of bile salts, which may also contribute to an increase in CBD bioaccessibility. The food matrix used was a mixture of olive oil and baby food. Overall, the fed-state digestion revealed significantly higher micellarization efficiency for CBD (14.15 ± 0.6% for 10 mg and 22.67 ± 2.1% for 100 mg CBD ingested) than the fasted state digestion of CBD (0.65 ± 0.7% for 10 mg and 0.14 ± 0.1% for 100 mg CBD ingested). The increase in bioaccessibility of CBD with food could be explained by the fact that micelle formation from hydrolyzed lipids aid in bioaccessibility of hydrophobic molecules. In conclusion, the bioaccessibility of CBD depends on the food matrix and the presence of lipase and bile salts.
大麻二酚(CBD)是一种具有治疗特性的疏水性非精神活性化合物。动物和人体研究表明其在体内口服生物利用度较差,并且尚未探究食用脂溶性CBD时有无食物对肠道生物可及性的影响。本研究的目的是通过有食物和无食物的三相上消化道消化实验来研究CBD的生物可及性,并测试不同底物浓度下的脂肪酶活性。我们的结果表明,在存在胆盐的情况下脂肪酶活性和脂肪酸吸收增加,这也可能有助于提高CBD的生物可及性。所使用的食物基质是橄榄油和婴儿食品的混合物。总体而言,与禁食状态下CBD的消化(摄入10mg时为0.65±0.7%,摄入100mg时为0.14±0.1%)相比,进食状态下的消化显示CBD的胶束化效率显著更高(摄入10mg时为14.15±0.6%,摄入100mg时为22.67±2.1%)。食物使CBD生物可及性增加的原因可能是水解脂质形成的胶束有助于疏水分子的生物可及性。总之,CBD的生物可及性取决于食物基质以及脂肪酶和胆盐的存在。